Choose Language Top Menu Main Menu Extra Button Menu Page Contents Footer Search

• Activate the claw-back mechanism that maintains outpatient pharmaceutical spending within budget limits; €2.88bn in 2012, €2.44bn in 2013 and €2.0bn in 2014
• Revise downward the price of medicines, based on the three EU countries with the lowest prices
• Revise the fees for a number of diagnostic and physiotherapy services contracted by EOPYY to private providers with the aim of reducing related costs by at least €80mn in 2013.